Abstract
This study reports the preliminary results of a Frailty program involving all allo-HCT candidates, initiated at our institution in April 2021. The program started with the assessment of patients’ frailty at first consultation and at transplant admission using the HCT Frailty Scale. After observing the dynamics of the frailty syndrome, in June 2022 the program incorporated an individualized 4-8-weeks pre-habilitation program composed by personalized home-based exercise regimens to mitigate or prevent patients’ frailty at transplantation. This study includes the 120 patients transplanted during the program, 58 of them participating in the pre-habilitation program. The results indicate that the distribution of frailty was the same in first consultation and at HCT admission in non-pre-habilitated patients, but it changed from the proportions of fit, pre-frail and frail patients of 22.8%, 66.7%, 10.5% at first consultation, to the proportions 45.6%, 50.9% and 3.5% (P = 0.041) at admission in the pre-habilitated ones. And that the likelihood of OS was lower in the frail than in the fit and the pre-frail groups (1-year OS: 45.7% vs. 77.2%, O = 0.021). Therefore, the study provides preliminary evidence that pre habilitation programs significantly reduces frailty among transplant candidates and, eventually, increase the likelihood of OS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others
Data availability
Data sharing would be only considered after specific request.
References
Passweg JR, Baldomero H, Chabannon C, Basak GW, de la Camara R, Corbacioglu S, et al. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years. Bone Marrow Transpl 2021;56:1651–64.
Snowden JA, Sanchez-Ortega I, Corbacioglu S, Basak GW, Chabannon C, de la Camara R, et al. Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022. Bone Marrow Transpl 2022;57:1217–39.
Penack O, Peczynski C, Mohty M, Yakoub-Agha I, Styczynski J, Montoto S, et al. How much has allogeneic stem cell transplant-related mortality improved since the 1980s? A retrospective analysis from the EBMT. Blood Adv 2020;4:6283–90.
Salas MQ, Charry P, Pedraza A, Martinez-Cibrian N, Solano MT, Domenech A, et al. PTCY and Tacrolimus for GVHD prevention for older adults undergoing HLA-matched sibling and unrelated donor AlloHCT. Transplant Cell Ther. 2022;28:489.e1–489.e9.
Abel GA, Klepin HD. Frailty and the management of hematologic malignancies. Blood 2018;131:515–24.
Scheepers ERM, Vondeling AM, Thielen N, van der Griend R, Stauder R, Hamaker ME. Geriatric assessment in older patients with a hematologic malignancy: a systematic review. Haematologica 2020;105:1484–93.
Klepin HD. Ready for prime time: role for geriatric assessment to improve quality of care in hematology practice. Blood 2019;134:2005–12.
Kanate AS, Perales MA, Hamadani M. Eligibility criteria for patients undergoing allogeneic hematopoietic cell transplantation. J Natl Compr Canc Netw 2020;18:635–43.
Jayani R, Rosko A, Olin R, Artz A. Use of geriatric assessment in hematopoietic cell transplant. J Geriatr Oncol. 2019;11:225–36.
Klepin HD, Wildes TM. Fighting for the integration of geriatric principles into oncology. J Geriatr Oncol 2018;9:705–6.
Williams GR, Deal AM, Jolly TA, Alston SM, Gordon BB, Dixon SA, et al. Feasibility of geriatric assessment in community oncology clinics. J Geriatr Oncol 2014;5:245–51.
Hamaker ME, Wildes TM, Rostoft S. Time to stop saying geriatric assessment is too time consuming. J Clin Oncol 2017;35:2871–4.
Muffly LS, Kocherginsky M, Stock W, Chu Q, Bishop MR, Godley LA, et al. Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients. Haematologica 2014;99:1373–9.
Deschler B, Ihorst G, Schnitzler S, Bertz H, Finke J. Geriatric assessment and quality of life in older patients considered for allogeneic hematopoietic cell transplantation: a prospective risk factor and serial assessment analysis. Bone Marrow Transpl 2018;53:565–75.
Derman BA, Kordas K, Ridgeway J, Chow S, Dale W, Lee SM, et al. Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults. Blood Adv 2019;3:3488–98.
Holmes HM, Des Bordes JK, Kebriaei P, Yennu S, Champlin RE, Giralt S, et al. Optimal screening for geriatric assessment in older allogeneic hematopoietic cell transplantation candidates. J Geriatr Oncol 2014;5:422–30.
Lin RJ, Elko TA, Devlin SM, Shahrokni A, Jakubowski AA, Dahi PB, et al. Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies. Bone Marrow Transplant. 2019;55:157–64.
Nawas MT, Andreadis C, Martin TG, Wolf JL, Ai WZ, Kaplan LD, et al. Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell Transplantation. Biol Blood Marrow Transpl 2019;25:1218–24.
Salas MQ, Atenafu EG, Bascom O, Wilson L, Lam W, Law AD, et al. Pilot prospective study of Frailty and Functionality in routine clinical assessment in allogeneic hematopoietic cell transplantation. Bone Marrow Transpl 2021;56:60–69.
Salas MQ, Atenafu EG, Pasic I, Al-Shaibani E, Bascom O, Wilson L, et al. Impact of hematopoietic cell transplant frailty scale on transplant outcome in adults. Bone Marrow Transplant. 2022;58:317–24.
Salas MQ, Atenafu EG, Pasic I, Bascom O, Wilson L, Lam W, et al. HCT frailty scale for younger and older adults undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transpl 2023;58:1237–46.
Salas MQ, Atenafu EG, Pasic I, Al-Shaibani E, Bascom O, Wilson L, et al. Impact of hematopoietic cell transplant frailty scale on transplant outcome in adults. Bone Marrow Transpl 2023;58:317–24.
Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005;173:489–95.
Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179–86.
Bohannon RW. Hand-grip dynamometry predicts future outcomes in aging adults. J Geriatr Phys Ther 2008;31:3–10.
Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991;39:142–8.
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transpl 2013;48:452–8.
Olin RL, Fretham C, Pasquini MC, Arora M, Bhatt VR, Derman B, et al. Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes. Blood Adv 2020;4:2810–20.
Arora M, Sun CL, Ness KK, Teh JB, Wu J, Francisco L, et al. Physiologic frailty in nonelderly hematopoietic cell transplantation patients: results from the bone marrow transplant survivor study. JAMA Oncol 2016;2:1277–86.
Arora M, Chen Y, Wu J, Hageman L, Ness E, Kung M, et al. Longitudinal trajectory of frailty in blood or marrow transplant survivors: Report from the Blood or Marrow Transplant Survivor Study. Cancer 2021;127:794–800.
Bouillon K, Kivimaki M, Hamer M, Sabia S, Fransson EI, Singh-Manoux A, et al. Measures of frailty in population-based studies: an overview. BMC Geriatr 2013;13:64.
Gill TM, Gahbauer EA, Allore HG, Han L. Transitions between frailty states among community-living older persons. Arch Intern Med 2006;166:418–23.
Angulo J, El Assar M, Alvarez-Bustos A, Rodriguez-Manas L. Physical activity and exercise: strategies to manage frailty. Redox Biol 2020;35:101513.
Ni Lochlainn M, Cox NJ, Wilson T, Hayhoe RPG, Ramsay SE, Granic A, et al. Nutrition and frailty: opportunities for prevention and treatment. Nutrients. 2021;13:23–49.
Jayani RV, Pidala J, Jim H, Whiting J, Mo Q, Mishra A. Association of patient-reported physical activity on allogeneic hematopoietic cell transplant outcomes. Clin Hematol Int 2021;3:34–39.
Baumann FT, Zopf EM, Nykamp E, Kraut L, Schule K, Elter T, et al. Physical activity for patients undergoing an allogeneic hematopoietic stem cell transplantation: benefits of a moderate exercise intervention. Eur J Haematol 2011;87:148–56.
Jurdi NE, Nock N, Fu P, Cao S, Cotton JM, Ali N, et al. Physical activity and sleep measures using a fitness tracking device during hematopoietic cell transplantation: a pilot study. Transpl Cell Ther 2021;27:502 e1– e6.
Cheng JT, Obaisi O, Yadav R, Gupta E, Fu JB, Bruera E, et al. The role of outpatient physical medicine and rehabilitation in a multidisciplinary prehabilitation program for older adults before allogeneic hematopoietic stem cell transplant. Am J Phys Med Rehabil. 2024;103:710–5.
Mawson S, Keen C, Skilbeck J, Ross H, Smith L, Dixey J, et al. Feasibility and benefits of a structured prehabilitation programme prior to autologous stem cell transplantation (ASCT) in patients with myeloma; a prospective feasibility study. Physiotherapy 2021;113:88–99.
Wingard JR, Wood WA, Martens M, Le-Rademacher J, Logan B, Knight JM, et al. Pretransplantation exercise and hematopoietic cell transplantation survival: a secondary analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902). Biol Blood Marrow Transpl 2017;23:161–4.
Paolucci EM, Loukov D, Bowdish DME, Heisz JJ. Exercise reduces depression and inflammation but intensity matters. Biol Psychol 2018;133:79–84.
Luo B, Xiang D, Ji X, Chen X, Li R, Zhang S, et al. The anti-inflammatory effects of exercise on autoimmune diseases: A 20-year systematic review. J Sport Health Sci 2024;13:353–67.
Orange ST, Leslie J, Ross M, Mann DA, Wackerhage H. The exercise IL-6 enigma in cancer. Trends Endocrinol Metab 2023;34:749–63.
Thomas NE, Williams DR. Inflammatory factors, physical activity, and physical fitness in young people. Scand J Med Sci Sports 2008;18:543–56.
Salas MQ, Solano MT, Baile-González M, Acera-Gómez M, Sanchez-Salinas A, Salmeron-Camacho J, et al. Frailty assessment in adults undergoing allogeneic hematopoietic cell transplantation: insights from a multicenter GETH-TC study to optimize outcomes and care. Frontiers in Immunology. 2024.
Acknowledgements
We thank our patients and the nursing and medical staff at Hospital Clínic de Barcelona. The principal investigator is extremely grateful to Dr. Rajat Kumar and Dr. Shabbir Alibhai for their support during the study period.
Author information
Authors and Affiliations
Contributions
MQS designed the study, collected the data, performed statistical analysis, and wrote the paper. All the staff members and nursing team of the HCT Unit and the Rehabilitation Service at the Hospital Clínic de Barcelona have supported the implementation of this program into our clinical practice, and provided a valuable input into the present study. RS, CP, SL, CM, and CC carry out the pre-habilitation program. LG, MTS, CM, NDL, and CG perform the frailty evaluation of patients with the HCT Frailty Scale. RS, LG, MTS, CP, CM, PC, NDL, CM, EC, JC, ML, CG, SL, BC, VS, JM, MDR, JE, EC, MSL, LR, CC, CM, FFA, and MR contributed significantly to the study, offering valuable feedback, and critically reviewing and approving the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no relevant conflicts of interest, financial or otherwise.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Salas, M.Q., Salinas-González, R., Guardia, L. et al. Frailty assessment and outpatient pre-habilitation for adults undergoing allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 60, 841–850 (2025). https://doi.org/10.1038/s41409-025-02571-9
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41409-025-02571-9
This article is cited by
-
Newly diagnosed acute myeloid leukemia in unfit patients: 2026 treatment algorithms
Blood Cancer Journal (2025)